Calculation of your study is finished. Please find your results below.

A study for a 66 year old woman who takes Jardiance (an AI-powered real world drug study)

Summary:

4,167 females aged 66 (±5) who take the same drug and have adverse effects are studied. This is a phase IV clinical study for a 66 year old female patient who has Diabetes Mellitus. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 11, 2026

4,167 females aged 66 (±5) who take Jardiance and have adverse effects are studied.


Number of reports submitted per year:

Jardiance for a 66-year old woman.

Information of the patient in this study:

  • Age: 66
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Hair Loss:
    - among females aged 66 (±5) who take the same drug: 0.94% (39 of 4,167)
    - among people who take the same drug, regardless of gender or age: 0.64% (295 of 45,977)

By each condition:

  • people who have Hair Loss with Diabetes Mellitus:
    - among females aged 66 (±5) who have Diabetes Mellitus: 1.2% (446 of 37,273)
    - among people who have Diabetes Mellitus, regardless of gender or age: 0.5% (1,869 of 370,132)

By each drug (FDA data only):

  • people who take Jardiance and have Hair Loss:
    - among females aged 66 (±5) who take Jardiance and have side effects: 0.99% (39 of 3,938)
    - among people who take Jardiance and have side effects, regardless of gender or age: 0.67% (295 of 43,725)

Common side effects *:

  1. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 376 people, 9.02%
  2. Nausea (feeling of having an urge to vomit): 303 people, 7.27%
  3. Blood Glucose Increased : 297 people, 7.13%
  4. Fatigue (feeling of tiredness): 232 people, 5.57%
  5. Diarrhea : 228 people, 5.47%
  6. Fungal Infection : 211 people, 5.06%
  7. Dizziness : 202 people, 4.85%
  8. Nausea And Vomiting : 201 people, 4.82%
  9. Urinary Tract Infection : 174 people, 4.18%
  10. Weight Decreased : 170 people, 4.08%
  11. Dyspnea (difficult or laboured breathing): 157 people, 3.77%
  12. Drug Ineffective : 138 people, 3.31%
  13. Headache (pain in head): 136 people, 3.26%
  14. Malaise (a feeling of general discomfort or uneasiness): 124 people, 2.98%
  15. Weakness : 123 people, 2.95%
  16. Joint Pain : 118 people, 2.83%
  17. Fall : 102 people, 2.45%
  18. Dehydration (dryness resulting from the removal of water): 99 people, 2.38%
  19. Rashes (redness): 97 people, 2.33%
  20. High Blood Pressure : 95 people, 2.28%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Type 2 Diabetes : 1,647 people, 39.52%
  2. High Blood Pressure : 440 people, 10.56%
  3. High Blood Cholesterol : 277 people, 6.65%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 113 people, 2.71%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 112 people, 2.69%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 100 people, 2.40%
  7. Cardiac Failure : 88 people, 2.11%
  8. Depression : 87 people, 2.09%
  9. Asthma : 74 people, 1.78%
  10. Pain : 65 people, 1.56%
  11. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 65 people, 1.56%
  12. Psoriasis (immune-mediated disease that affects the skin): 55 people, 1.32%
  13. Thyroid Diseases : 49 people, 1.18%
  14. Stress And Anxiety : 47 people, 1.13%
  15. Hyperlipidaemia (presence of excess lipids in the blood): 45 people, 1.08%
  16. Multiple Myeloma (cancer of the plasma cells): 43 people, 1.03%
  17. Cardiac Disorder : 41 people, 0.98%
  18. Dyslipidaemia (abnormal amount of lipids): 38 people, 0.91%
  19. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 37 people, 0.89%
  20. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 36 people, 0.86%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Metformin (1,096 people, 26.30%)
  2. Trulicity (328 people, 7.87%)
  3. Amlodipine (218 people, 5.23%)
  4. Aspirin (198 people, 4.75%)
  5. Lantus (197 people, 4.73%)
  6. Vitamin D3 (173 people, 4.15%)
  7. Januvia (172 people, 4.13%)
  8. Ozempic (137 people, 3.29%)
  9. Lisinopril (131 people, 3.14%)
  10. Humalog (129 people, 3.10%)
  11. Synthroid (127 people, 3.05%)
  12. Eliquis (125 people, 3.00%)
  13. Tresiba (118 people, 2.83%)
  14. Spironolactone (117 people, 2.81%)
  15. Gabapentin (117 people, 2.81%)
  16. Crestor (114 people, 2.74%)
  17. Omeprazole (112 people, 2.69%)
  18. Furosemide (107 people, 2.57%)
  19. Vitamin D (105 people, 2.52%)
  20. Prednisone (102 people, 2.45%)

Drug effectiveness *:

Jardiance:
  • not at all: 3.33 %
  • somewhat: 18.33 %
  • moderate: 35.0 %
  • high: 33.33 %
  • very high: 10.0 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: